AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Vasilaki, A. T
Right arrow Articles by Talwar, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasilaki, A. T
Right arrow Articles by Talwar, D.
Agricola
Right arrow Articles by Vasilaki, A. T
Right arrow Articles by Talwar, D.
American Journal of Clinical Nutrition, Vol. 88, No. 1, 140-146, July 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells, and white cells in patients with critical illness1,2,3

Aikaterini T Vasilaki1, Donald C McMillan1, John Kinsella1, Andrew Duncan1, Denis St J O'Reilly1 and Dinesh Talwar1

1 From the University Departments of Surgery (ATV and DCM) and Anaesthesia (DTV and JK) and the Department of Biochemistry (ATV, AD, DSJO, and DT), Royal Infirmary, Glasgow, United Kingdom

Background:Evidence suggests that the relation between plasma and red cell vitamin B-6 concentrations is perturbed as part of the systemic inflammatory response in critically ill patients.

Objective:The aim was to examine the cross-sectional and longitudinal interrelations between pyridoxal (PL) and pyridoxal phosphate (PLP) concentrations in plasma and red and white cells in patients with critical illness.

Design:PLP and PL concentrations were measured by HPLC in plasma and red and white cells in normal subjects (n = 126) and critically ill patients (n = 96) on admission and on follow-up.

Results:On admission, compared with the controls, median plasma PLP and PL (P < 0.001 and < 0.01, respectively) and red cell PLP and PL (P < 0.001 and < 0.05, respectively) and their ratio (PLP:PL) in plasma and red cells (P < 0.001 and < 0.01, respectively) were significantly lower in the critically ill. In critically ill patients, plasma PLP:PL was significantly lower than red cell PLP:PL (P = 0.001) and white cell PLP:PL (P = 0.008). Plasma PL concentration was directly associated with both red cell PL (rs = 0.73, P < 0.001) and white cell PL (rs = 0.68, P < 0.001). Red cell PL and white cell PL were directly associated with red cell PLP (rs = 0.82, P < 0.001) and white cell PLP (rs = 0.68, P < 0.001), respectively. Longitudinal measurements (n = 48) were similar.

Conclusions:The relation between plasma PLP and PL was significantly perturbed in critical illness. This effect was less pronounced in red and white cells. Therefore, these results confirm the hypothesis that intracellular PLP concentrations are more likely to be a reliable measure of status than are plasma measurements in the critically ill patient.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition